The atrial appendage occluder market is on a remarkable growth trajectory, with a projected market size of USD 983.5 million in 2023, expected to surge to USD 8,193.0 million by 2033. This growth is ...

Here are four recent cardiology procedures that were the first-of-their-kind or the first in the state they were performed in, as reported by Becker's: ...

Most of our top stories this month stemmed from the ESC Congress—a mix of drug and device trials as well as guidelines.

Conformal Medical, Inc. today announced the initiation of the GLACE Study. This European study* aims to assess the use of intracardiac echocardiography (ICE) imaging of the left atrial appendage (LAA) ...

Conformal Medical, Inc. today announced the initiation of the GLACE Study. This European study* aims to assess the use of intracardiac echocardiography (ICE) imaging of the left atrial appendage (LAA) ...

The EnCompass Clamp includes the features of AtriCure’s existing Synergy™ Clamp family, such as parallel closure, uniform pressure ... AtriCure’s AtriClip® Left Atrial Appendage Exclusion System ...

Boston Scientific Corporation (NYSE: BSX ) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSETM Pulsed Field Ablation (PFA) System. The ...

The FARAPULSE PFA System, which is indicated for the isolation of pulmonary veins in the treatment of paroxysmal atrial fibrillation ... WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device.

Erlanger Cariology celebrated the completion of its 500 th left atrial appendage closure (LAAC) procedure on September 25th. LACC devices aid patients with atrial fibrillations (AFib) by closing ...

Virginia’s “Left Lane law” makes it illegal to drive slower than the speed limit in left lanes on any of the state’s highways. But an AAA survey found many drivers see drivers violating ...